The PD-L1/PD-1 signaling pathway is a crucial component of tumor immunosuppression; however, the expression of PD-L1 is regulated by complex mechanisms, including gene transcription as well as post-transcriptional and post-translational modifications. The gene discussed is CD274; the disease is neoplasm.